" class="no-js "lang="en-US"> Drug Development Archives - Page 38 of 40 - Medtech Alert
Tuesday, June 30, 2026

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors

Sort by:

Date

Top Post

Google Cloud Launches AI-powered Solutions to Safely Accelerate Drug Discovery and Precision Medicine | MTA

Google Cloud Launches AI-powered Solutions to Safely Accelerate Drug Discovery and Precision Medicine

Google Cloud has announced two new AI-powered life sciences solutions to accelerate drug discovery and […]

Read more

Diseases

 Libtayo ® (Cemiplimab) Receives Positive CHMP Opinion for the Treatment in Europe of Two Advanced Cancers | Pharmtech Focus

Libtayo ® (Cemiplimab) Receives Positive CHMP Opinion for the Treatment in Europe of Two Advanced Cancers

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted […]

Drug Development

 NovAliX Expands Cryo-electron Microscopy (Cryo-EM) Capabilities for Drug Development Offering | Pharmtech Focus

NovAliX Expands Cryo-electron Microscopy (Cryo-EM) Capabilities for Drug Development Offering

NovAliX, a drug discovery-focused Contract Research Organization (CRO), today announces the expansion of its cryogenic […]

Clinical Trials

 Exscientia Announces Second Molecule Created Using AI from Sumitomo Dainippon Pharma Collaboration to Enter Phase 1 Clinical Trial | Pharmtech Focus

Exscientia Announces Second Molecule Created Using AI from Sumitomo Dainippon Pharma Collaboration to Enter Phase 1 Clinical Trial

Exscientia Ltd. (Headquarters: Oxford, UK; CEO: Andrew Hopkins) is pleased to acknowledge that Sumitomo Dainippon Pharma Co., […]

Drug Development

 AbbVie’s RINVOQ® ▼ (upadacitinib) Accepted for Use | Pharmtech Focus

AbbVie’s RINVOQ® ▼ (upadacitinib) Accepted for Use

AbbVie (NYSE: ABBV) today announced that the Scottish Medicines Consortium (SMC) has issued a positive […]

Drug Development

 Flagship Pioneering Unveils Laronde to Advance Endless RNA™ | Pharmtech Focus

Flagship Pioneering Unveils Laronde to Advance Endless RNA™

Flagship Pioneering today unveiled Laronde, a platform company developing Endless RNA™ (eRNA), a novel, engineered […]

Clinical Trials

 Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate (NanoFlu/NVX-CoV2373) | Pharmtech Focus

Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate (NanoFlu/NVX-CoV2373)

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced […]

Drug Development

 FDA Accepts Amgen's Supplemental New Drug Application For Otezla ® (apremilast) For Adults With Mild-To-Moderate Plaque Psoriasis | Pharmtech Focus

FDA Accepts Amgen's sNDA For Otezla ®

Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for […]

Drug Development

 European Commission Approves Benlysta for Adult Patients with Active Lupus Nephritis | Pharmtech Focus

EU Commission Approves Benlysta for Lupus Nephritis

GlaxoSmithKline plc (GSK) today announced the European Commission has approved the expanded use of intravenous […]

Diseases

 ViiV Healthcare New Drug Application for Long-Acting Cabotegravir for Prevention of HIV | Pharmtech Focus

ViiV Healthcare New Drug Application for Long-Acting Cabotegravir for Prevention of HIV

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer […]

Drug Development

 Cannabics Pharmaceuticals Launches a New Research Program to develop a Melanoma Treatment Drug Candidate for FDA Approval Track | Pharmtech Focus

Cannabics Pharmaceuticals Launches a New Research Program to Develop a Melanoma Treatment Drug Candidate for FDA Approval Track

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients

    Clinical Trials

     Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS

    Clinical Trials

     Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board

    Appointments

     Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera

    News

     Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic

    Clinical Trials

     Read more